Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

As the number of actionable biomarkers in thoracic oncology continues to grow, the role of the multidisciplinary care team evolves to ensure patients receive comprehensive biomarker testing and ...

Urs Weber, MD, discusses why comprehensive NGS is critical and where community biomarker testing often falls short.

Texas-based Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests for early lung and gastric cancers, today announced the commercial launch of its proprietary CIZ1B Biomarker Blood ...

Dr. John Marshall explains why biomarker testing should be done early in colorectal cancer to guide treatment and identify targeted therapies. Biomarker testing is no longer optional in colorectal ...

Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to ...

With more than 150,000 new colorectal cancer cases diagnosed annually in the United States, metastatic colorectal cancer (mCRC) remains an area of significant unmet medical need.

Recently validated markers have helped improve treatment but more are needed ...

Cancer advocates, patients and doctors gathered at the North Carolina Legislature on Tuesday to support legislation aimed at expanding access to biomarker testing for cancer patients across the state.

Add Yahoo as a preferred source to see more of our stories on Google. There are 24 states that mandate insurance companies to cover the cost of a biomarker test, according to the American Cancer ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...